Cargando…

Multimodal Treatments for Brain Metastases from Renal Cell Carcinoma: Results of a Multicentric Retrospective Study

SIMPLE SUMMARY: Around 2–15% of primary renal cell carcinoma patients (RCC) will develop brain metastases (BMs) during the disease course. The prognosis of brain metastatic RCC patients is poor when compared with extracranial metastatic patients, and determining the optimal local therapeutic approac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Navarria, Pierina, Pessina, Federico, Minniti, Giuseppe, Franzese, Ciro, Marini, Beatrice, D’agostino, Giuseppe, Badalamenti, Marco, Raspagliesi, Luca, Reggiori, Giacomo, Lobefalo, Francesca, Fariselli, Laura, Franceschini, Davide, Bellu, Luisa, Clerici, Elena, Pinzi, Valentina, Scorsetti, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000216/ https://www.ncbi.nlm.nih.gov/pubmed/36900186 http://dx.doi.org/10.3390/cancers15051393

Ejemplares similares

Radiosurgery of limited brain metastases from primary solid tumor: results of the randomized phase III trial (NCT02355613) comparing treatments executed with a specialized or a C-arm linac-based platform
por: Scorsetti, Marta, et al.
Publicado: (2023)

Can advanced new radiation therapy technologies improve outcome of high grade glioma (HGG) patients? analysis of 3D-conformal radiotherapy (3DCRT) versus volumetric-modulated arc therapy (VMAT) in patients treated with surgery, concomitant and adjuvant chemo-radiotherapy
por: Navarria, Pierina, et al.
Publicado: (2016)

The efficacy of Stereotactic body radiation therapy and the impact of systemic treatments in oligometastatic patients from prostate cancer
por: Franzese, Ciro, et al.
Publicado: (2018)

Hypo-fractionated stereotactic radiotherapy alone using volumetric modulated arc therapy for patients with single, large brain metastases unsuitable for surgical resection
por: Navarria, Pierina, et al.
Publicado: (2016)

Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery
por: Franzese, Ciro, et al.
Publicado: (2017)

Training and validation of a knowledge-based dose-volume histogram predictive model in the optimisation of intensity-modulated proton and volumetric modulated arc photon plans for pleural mesothelioma patients
por: Franceschini, Davide, et al.
Publicado: (2022)

Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy
por: Franzese, Ciro, et al.
Publicado: (2015)

Adaptive Volumetric-Modulated Arc Radiation Therapy for Head and Neck Cancer: Evaluation of Benefit on Target Coverage and Sparing of Organs at Risk
por: Franzese, Ciro, et al.
Publicado: (2023)

Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma
por: Scorsetti, Marta, et al.
Publicado: (2015)

Knowledge-based DVH estimation and optimization for breast VMAT plans with and without avoidance sectors
por: Fogliata, Antonella, et al.
Publicado: (2022)

RapidPlan knowledge based planning: iterative learning process and model ability to steer planning strategies
por: Fogliata, A., et al.
Publicado: (2019)

Dosimetric impact of volumetric modulated arc therapy for nasopharyngeal cancer treatment
por: Franzese, Ciro, et al.
Publicado: (2021)

Twenty Years of Advancements in a Radiotherapy Facility: Clinical Protocols, Technology, and Management
por: Tomatis, Stefano, et al.
Publicado: (2023)

RapidPlan head and neck model: the objectives and possible clinical benefit
por: Fogliata, A., et al.
Publicado: (2017)

Stereotactic Radiotherapy for Parasagittal and Parafalcine Meningiomas: Patient Selection and Special Considerations
por: Pinzi, V, et al.
Publicado: (2019)

The Potential Role of Intensity-Modulated Proton Therapy in Hepatic Carcinoma in Mitigating the Risk of Dose De-Escalation
por: Cozzi, Luca, et al.
Publicado: (2020)

Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up
por: Scorsetti, Marta, et al.
Publicado: (2018)

Volumetric modulated arc therapy for thoracic node metastases: a safe and effective treatment for a neglected disease
por: Franceschini, Davide, et al.
Publicado: (2016)

Hypofractionated Stereotactic Radiation Therapy in Recurrent High-Grade Glioma: A New Challenge
por: Navarria, Pierina, et al.
Publicado: (2016)

Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
por: Navarria, Pierina, et al.
Publicado: (2014)

Volumetric modulated arc therapy with flattening filter free beams for isolated abdominal/pelvic lymph nodes: report of dosimetric and early clinical results in oligometastatic patients
por: Alongi, Filippo, et al.
Publicado: (2012)

Radiomics based analysis to predict local control and survival in hepatocellular carcinoma patients treated with volumetric modulated arc therapy
por: Cozzi, Luca, et al.
Publicado: (2017)

Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results
por: De Rose, Fiorenza, et al.
Publicado: (2016)

Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin’s lymphoma. Assessment of risk of toxicity and secondary cancer induction
por: Scorsetti, Marta, et al.
Publicado: (2020)

Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer? Long-Term Clinical Outcomes, Toxicity and Prognostic Factors on 142 Patients (STEP Study)
por: Comito, Tiziana, et al.
Publicado: (2023)

Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study
por: Alongi, Filippo, et al.
Publicado: (2013)

Outcome Evaluation of Oligometastatic Patients Treated with Surgical Resection Followed by Hypofractionated Stereotactic Radiosurgery (HSRS) on the Tumor Bed, for Single, Large Brain Metastases
por: Pessina, Federico, et al.
Publicado: (2016)

Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma
por: Cozzi, Luca, et al.
Publicado: (2019)

Anatomy driven optimization strategy for total marrow irradiation with a volumetric modulated arc therapy technique
por: Mancosu, Pietro, et al.
Publicado: (2012)

Stereotactic radiation therapy for oligometastatic esophagogastric adenocarcinoma: outcome and prognostic factors
por: Franceschini, Davide, et al.
Publicado: (2023)

In-vivo dosimetry with Gafchromic films for multi-isocentric VMAT irradiation of total marrow lymph-nodes: a feasibility study
por: Mancosu, Pietro, et al.
Publicado: (2015)

Role of 11C Methionine Positron Emission Tomography (11CMETPET) for Surgery and Radiation Therapy Planning in Newly Diagnosed Glioblastoma Patients Enrolled into a Phase II Clinical Study
por: Pessina, Federico, et al.
Publicado: (2021)

Knowing When to Use Stereotactic Ablative Radiation Therapy in Oligometastatic Cancer
por: Franceschini, Davide, et al.
Publicado: (2021)

Locally Advanced Non-Small Cell Lung Cancer: Clinical Outcome, Toxicity and Predictive Factors in Patients Treated with Hypofractionated Sequential or Exclusive Radiotherapy
por: Massaro, Maria, et al.
Publicado: (2022)

Stereotactic Radiotherapy for Ultra-Central Lung Oligometastases in Non-Small-Cell Lung Cancer
por: Loi, Mauro, et al.
Publicado: (2020)

SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience
por: Tozzi, Angelo, et al.
Publicado: (2013)

Cone beam CT pre‐ and post‐daily treatment for assessing geometrical and dosimetric intrafraction variability during radiotherapy of prostate cancer
por: Reggiori, Giacomo, et al.
Publicado: (2010)

Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE\TACE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360)
por: Comito, Tiziana, et al.
Publicado: (2022)

Evaluation of plan complexity and dosimetric plan quality of total marrow and lymphoid irradiation using volumetric modulated arc therapy
por: Lambri, Nicola, et al.
Publicado: (2023)

Dosimetric impact of inter-observer variability for 3D conformal radiotherapy and volumetric modulated arc therapy: the rectal tumor target definition case
por: Lobefalo, Francesca, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7fv2agsg1gsrb214v2fdpqrduf